Target intelligence / Profile preview

Bacterial DNA synthesis pathway

Molecular classification
Enzyme, Protein complex
01

Overview

The bacterial DNA synthesis pathway encompasses the entire coordinated sequence of molecular events required to accurately duplicate the bacterial chromosome prior to cell division[3][7]. This process is mediated by the coordinated action of an array of enzymes and protein complexes commonly referred to as the "replisome," including DNA polymerase III (responsible for the bulk of DNA synthesis), DNA gyrase and topoisomerase IV (resolve topological stress by introducing or removing supercoils), helicase (DnaB), primase (DnaG, for RNA primer synthesis), and several accessory proteins such as single-stranded DNA binding protein, clamp loader, and ligase[5][7]. Drugs targeting this pathway typically block one or more essential enzymatic reactions, resulting in inhibition of bacterial cell proliferation. The pathway is a major antibacterial drug target, although effective therapeutic exploitation requires specificity for bacterial enzymes over their eukaryotic counterparts to minimize host toxicity. Note: For therapeutic development, it is best practice to reference specific molecular targets (e.g., "DNA gyrase") rather than the entire pathway, which is a functional grouping and not a discrete molecule[4][7].

Other names
Bacterial DNA replication pathwayBacterial DNA replication machineryBacterial DNA replication
02

Mechanism of action

Inhibition of DNA gyrase/topoisomerase II: blocks supercoiling and uncoiling, halting DNA replication. Inhibition of DNA polymerase III: prevents DNA chain elongation. Inhibition of DNA primase or helicase: blocks primer synthesis or DNA strand separation. Formation of DNA adducts: crosslinks DNA, preventing replication and transcription.

03

Biological functions

DNA replicationGenome duplicationCell divisionChromosome segregation
04

Disease associations

InfectionOther (no direct link to cancer or other non-infectious diseases except via horizontal gene transfer or resistance)
05

Safety considerations

Off-target effects on human mitochondrial DNA polymerase (rare for most antibiotics, more for anticancer analogs)Resistance development: mutations in target enzymes or uptake/efflux mechanismsDisruption of microbiome: broad-acting DNA synthesis inhibitors can disturb beneficial bacteria
06

Interacting drugs

Quinolones (e.g., ciprofloxacin, levofloxacin)

4 more in the full profile.

07

Biomarkers

Mutation in DNA gyrase or topoisomerase genes (e.g., gyrA, parC)Presence of plasmid-encoded resistance genes (e.g., qnr)

Beyond the preview

Go deeper on Bacterial DNA synthesis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA synthesis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call